![Nikki Adetoro](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nikki Adetoro
Nessuna posizione attualmente
Profilo
Nikki Adetoro worked as the VP of Clinical Operations & Project Management at Symbiomix Therapeutics LLC.
She is a graduate of The Johns Hopkins University.
Precedenti posizioni note di Nikki Adetoro
Società | Posizione | Fine |
---|---|---|
Symbiomix Therapeutics LLC
![]() Symbiomix Therapeutics LLC BiotechnologyHealth Technology Symbiomix Therapeutics LLC develops medicines for women’s health infections and related diseases. It offers SYM-1219, a drug that contains secnidazole that facilitate administration as a single-dose oral therapy for various women's health infections including bacterial vaginosis. The company was founded by Jack Roberts, Steve Pomerantz and Joseph L. Amprey III in 2012 and is headquartered in Newark, NJ. | Corporate Officer/Principal | 01/03/2018 |
Formazione di Nikki Adetoro
The Johns Hopkins University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Symbiomix Therapeutics LLC
![]() Symbiomix Therapeutics LLC BiotechnologyHealth Technology Symbiomix Therapeutics LLC develops medicines for women’s health infections and related diseases. It offers SYM-1219, a drug that contains secnidazole that facilitate administration as a single-dose oral therapy for various women's health infections including bacterial vaginosis. The company was founded by Jack Roberts, Steve Pomerantz and Joseph L. Amprey III in 2012 and is headquartered in Newark, NJ. | Health Technology |
- Borsa valori
- Insiders
- Nikki Adetoro